Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ESR1 degraders(Estrogen receptor alpha degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization EnhancedBio, Inc.Startup |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
ER-positive/HER2-negative Breast Cancer | Phase 2 | KR | 16 Sep 2022 | |
ER-positive/HER2-negative Breast Cancer | Phase 2 | KR | EnhancedBio, Inc.Startup | 16 Sep 2022 |